The Covid-19 NMR Consortium was born out of the need for a fast response to the threat of the pandemic. Early on, researchers realised that a critical success factor in combating the spread of the virus was to collaborate on a global scale, overturning the traditional model and sharing scientific results immediately.
Key to overcoming the SARS-CoV-2 virus is to understand its structure – and the goal of the Covid-19 NMR Consortium is to change the way the scientific community collaborates, breaking down barriers to work transparently and internationally, to achieve results far more quickly. The consortium uses NMR spectroscopy to analyze the RNA and protein components of the virus, and how they are structured. The aims of the research are two fold: firstly to find a treatment for SARS-CoV-2 through supporting the development of effective anti-viral drugs and secondly to investigate the impact of viral mutations through an understanding of how the structure of the viral proteins has changed as a result.
Tuesday June 15, 2021
Prof. Mei Hong
Professor of Chemistry - Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA